CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer

BACKGROUND: Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC). CA 15-3 measures the protein product of the MUC1 gene and is the most widely used serum marker in breast cancer. METHODS: We retrospectively investigated the role of CA 15-3 in conjunction with othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-azawi, Dhafir, Kelly, Gabrielle, Myers, Eddie, McDermott, Enda W, Hill, Arnold DK, Duffy, Michael J, Higgins, Niall O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590047/
https://www.ncbi.nlm.nih.gov/pubmed/16953875
http://dx.doi.org/10.1186/1471-2407-6-220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590047/
https://www.ncbi.nlm.nih.gov/pubmed/16953875
http://dx.doi.org/10.1186/1471-2407-6-220

Ejemplares similares